Who should be prioritised for COVID-19 vaccination?

被引:52
|
作者
Russell, Fiona M. [1 ,2 ]
Greenwood, Brian [3 ]
机构
[1] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
[2] Murdoch Childrens Res Inst, Asia Pacific Hlth Res, Melbourne, Vic, Australia
[3] London Sch Hyg & Trop Med, Dept Dis Control, London, England
基金
英国医学研究理事会;
关键词
COVID-19; vaccines; high-risk; epidemiology; transmission; vaccine development; clinical trials; WOMEN;
D O I
10.1080/21645515.2020.1827882
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The development of COVID-19 vaccines is occurring at a rapid pace, with the potential for a vaccine to be available within 6 months. So who should be prioritized for vaccination when in the first instance, there will be insufficient supply to meet demand? There is no doubt that health-care workers in all settings should be vaccinated first, but who comes next will be a complex decision based on local epidemiology, societal values, and the ability of the vaccines to prevent both severe disease and to reduce transmission thereby eliciting herd protection. The decision on who to vaccinate should be equitable, highly contextualized, and based on the property of each vaccine. In some settings, the elderly may be prioritized, in others, it may be the population most likely to get infected and responsible for community spread. To support decision-making on who to be prioritized for vaccination requires urgent additional research on the epidemiology of COVID-19; preexisting immunity and who is responsible for transmission in a variety of settings; the safety, immunogenicity, and efficacy of COVID-19 vaccines in children and pregnant women; and determining whether COVID-19 vaccines prevent asymptomatic infection and transmission.
引用
收藏
页码:1317 / 1321
页数:5
相关论文
共 50 条
  • [31] Predicting COVID-19 vaccination response in populations who are immunosuppressed
    Bechman, Katie
    Russell, Mark D.
    Galloway, James B.
    LANCET RHEUMATOLOGY, 2023, 5 (08): : E431 - E432
  • [32] Progress with COVID-19 vaccination in the WHO African Region in 2021
    Masresha, Balcha
    Poy, Alain
    Weldegebriel, Goitom
    Mbuyita, Selemani
    Fussum, Daniel
    Bwaka, Ado
    Paluku, Gilson
    Atuhebwe, Phionah
    Mihigo, Richard
    Impouma, Benido
    PAN AFRICAN MEDICAL JOURNAL, 2022, 41
  • [33] COVID-19 vaccination: returning to WHO's Health For All
    Torres, Irene
    Artaza, Osvaldo
    Profeta, Barbara
    Alonso, Cristina
    Kang, JaHyun
    LANCET GLOBAL HEALTH, 2020, 8 (11): : E1355 - E1356
  • [34] Defer vaccination of people who have had covid-19
    Bhopal, Raj
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
  • [36] Should healthcare workers be prioritised during the COVID-19 pandemic? A view from Madrid and New York
    Real de Asua, Diego
    Fins, Joseph J.
    JOURNAL OF MEDICAL ETHICS, 2022, 48 (06) : 397 - 400
  • [37] The COVID-19 vaccination
    Casas, Irma
    Mena, Guillermo
    MEDICINA CLINICA, 2021, 156 (10): : 500 - 502
  • [38] COVID-19 vaccination in cancer patients: Is it the time or should we wait?
    Arambulo, Stella
    Cabezas-Camarero, Santiago
    Rojas, Heinz
    Sotelo, Miguel
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (06) : 1588 - 1589
  • [39] COVID-19 Vaccination Should not be Mandatory for Health and Social Care Workers
    Rodger, Daniel
    Blackshaw, Bruce P.
    NEW BIOETHICS-A MULTIDISCIPLINARY JOURNAL OF BIOTECHNOLOGY AND THE BODY, 2022, 28 (01): : 27 - 39
  • [40] Should people with severe mental illness be prioritized for the COVID-19 vaccination?
    Yang, Yuan
    Li, Wen
    Zhang, Qinge
    Zhang, Ling
    Cheung, Teris
    Ng, Chee H.
    Xiang, Yu-Tao
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (06): : 1443 - 1445